Literature DB >> 3412555

Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases.

A McRae-Degueurce1, L Rosengren, K Haglid, S Bööj, C G Gottfries, A C Granérus, A Dahlström.   

Abstract

The CSF and sera of 7 patients with Parkinson's disease were investigated immunocytochemically, in order to see if antibodies were present which recognized DA-ergic cell bodies in glutaraldehyde fixed rat brain. In 2 patients a marked labeling of DA-ergic neurons in the substantia nigra was observed, identified by anti-DA antiserum and by 6-OHDA induced degeneration, but also other neurons in the ventral mesencephalon were recognized. The other patients were weakly positive or negative. Sera gave unspecific labelling of all neurons. In one patient the sub-classes of IgG were investigated and found to be of IgG3 (labeling nerve terminals) and of IgG1-2, low affinity type (recognizing perikarya). The epitopes recognized have not been identified, but are unlikely to be DA-like, since blocking experiments and ELISA-tests gave negative results. The possible clinical importance of the results are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3412555     DOI: 10.1007/bf00973287

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  6 in total

Review 1.  Etiology of Parkinson's disease: current concepts.

Authors:  R C Duvoisin
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

2.  The monoamine metabolism in viral encephalitides of the mouse. I. Virological and biochemical results.

Authors:  E Lycke; K Modigh; B E Roos
Journal:  Brain Res       Date:  1970-10-13       Impact factor: 3.252

3.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz; K Jellinger; F Seitelberger
Journal:  J Neurol Sci       Date:  1973-12       Impact factor: 3.181

4.  Nucleic acid homology studies of viral nucleic acids in idiopathic Parkinson's disease.

Authors:  J G Wetmur; J Schwartz; T S Elizan
Journal:  Arch Neurol       Date:  1979-08

5.  The monoamine metabolism in viral encephalitides of the mouse. II. Turnover of monoamines in mice infected with herpes simplex virus.

Authors:  E Lycke; B E Roos
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

6.  Herpes simplex virus antibodies in patients with Parkinson's disease.

Authors:  R J Marttila; U K Rinne
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

  6 in total
  10 in total

Review 1.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 4.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 5.  Early Parkinson's disease: what is the best approach to treatment.

Authors:  A H Hristova; W C Koller
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 6.  Pathways towards an effective immunotherapy for Parkinson's disease.

Authors:  Jessica A L Hutter-Saunders; Rodney Lee Mosley; Howard E Gendelman
Journal:  Expert Rev Neurother       Date:  2011-12       Impact factor: 4.618

7.  Experimental study of serum substantia nigra neuron autoantibody and its effect in Parkinson disease patients.

Authors:  J Chen; X Cao; Y Xu; S Sun
Journal:  J Tongji Med Univ       Date:  2001

8.  Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice.

Authors:  Randy L Hunter; Baohua Cheng; Dong-Young Choi; Mei Liu; Shuwei Liu; Wayne A Cass; Guoying Bing
Journal:  J Neurosci Res       Date:  2009-06       Impact factor: 4.164

9.  High-fat-diet exposure induces IgG accumulation in hypothalamic microglia.

Authors:  Chun-Xia Yi; Matthias H Tschöp; Stephen C Woods; Susanna M Hofmann
Journal:  Dis Model Mech       Date:  2012-03-01       Impact factor: 5.758

10.  Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression.

Authors:  Victor C Huber; Tapan Mondal; Stewart A Factor; Richard F Seegal; David A Lawrence
Journal:  J Neuroinflammation       Date:  2006-01-20       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.